Navigation Links
Stereotaxis' Market Leadership Highlighted at Heart Rhythm 2008
Date:5/9/2008

Odyssey Cinema. Odyssey Cinema enables

physicians to receive a real-time high definition view of a procedure

from any point in the network of installed Odyssey Systems. It also

includes a powerful archiving capability that will allow clinicians to

store and replay entire procedures or segments of procedures, thereby

providing them with a significant new tool for clinical collaboration,

remote consultation, and training.

o Previewing Navigant 3.0 -- Navigant 3.0 is the next generation software

for Niobe focused on simplification, automation, and enhanced

integration. New capabilities include automatic registration with x-ray

and mapping systems, enhanced automation features, and re-targeting to

compensate for movement. Stereotaxis believes that, particularly when

used in combination with Odyssey, Navigant 3.0 will significantly

advance EP lab productivity and procedural workflow efficiency.

"With its Niobe Magnetic Navigation and Odyssey information management systems, Stereotaxis has built a powerful platform to advance the practice of electrophysiology well into the future, and we are confident that it will continue to transform interventional medicine in important ways," said Bevil Hogg, CEO of Stereotaxis. "We are delighted to see how pervasive a role Stereotaxis' platform is playing at Heart Rhythm 2008, fully independent of our own corporate initiatives and programs, and we view this as a profound endorsement of the simplicity, safety and efficacy of the Niobe system, as approximately 15,000 procedures have proven in every chamber of the heart. It is our belief that clinicians and patients will always seek out the safest alternative. We are committed to meeting this expectation of our customers, and recognize that this is our surest route to success."

Heart Rhythm 2008, the Heart Rhythm Society's 29th Annual Scientific Sessions, will be held
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey(TM) Network
2. Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results
3. Stereotaxis Appoints David Burkhardt, M.D. as Chief Medical Officer
4. Stereotaxis Announces FDA Approval of Its Partnered Magnetic Irrigated Catheter
5. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
6. Amnis and Gene Company, Ltd. Announce Agreement to Market ImageStream Technology in China
7. Boston Scientific Announces European Approval and Market Launch of New Family of Advanced Pacemakers
8. LifeQuest World Launches Immune System Boosting Supplement to the North American Market
9. BioTrends Releases Two Publications - TreatmentTrends(TM): Nephrologists and TreatmentTrends(TM): Renal Dietitians - Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
10. Guided Surgery Technology Gaining Popularity in the Dental Implant Market
11. Trisha Dowling Joins Biomatrica as Vice President, Sales and Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... CTD Holdings, Inc. (OTCQB:CTDH), a manufacturer and distributor ... other markets, announced today that it has closed on ... investors led by Novit L.P., an investment arm of ... the signing of a Securities Purchase Agreement under which ... a price per share of $1.00, resulting in a ...
(Date:7/22/2014)... Parsippany, NJ (PRWEB) July 22, 2014 ... analytical, precision, portable, and mechanical balances and scales, ... precision balances has won Laboratory Equipment magazine’s 2014 ... is the second consecutive year the Explorer was ... readers. The annual Readers’ Choice Awards celebrates “excellence ...
(Date:7/22/2014)... and SHENZHEN, China , July ... LTD, (BGI Tech), a subsidiary of BGI, the ... launch of a new human whole exome sequencing ... newly offered service includes in-depth bioinformatics analysis and ... until December 31, 2014. Complete ...
(Date:7/22/2014)... Quorum Review IRB, the industry leader in central IRB ... Quick Step™ . The offering went live on July ... need for seamless study start-up with a large volume of ... 50 or more North American investigator sites, as well as ... of 80 or more. Qualifying studies may also enroll international ...
Breaking Biology Technology:CTD Holdings Closes $1.725 Million Private Placement 2CTD Holdings Closes $1.725 Million Private Placement 3OHAUS Explorer Voted “Best Balance” in Laboratory Equipment’s 2014 Readers’ Choice Awards 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 2BGI Tech Launches Human Whole Exome Sequencing Service on Complete Genomics' Advanced Platform 3Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 2Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 3
... EUREKA Cluster dedicated to Smart Systems Integration, will be ... community on 14-17 June 2011 in Helsinki, Finland. The ... the creation of new consortia and new projects by ... discuss proposals. EURIPIDES, in close cooperation with VTT and ...
... 20, 2011 Harvest Technologies Corp. ( www.harvesttech.com ) ... sixty patient Heart Failure trial have been enrolled at ... trial is intended to evaluate the safety and clinical ... patients with Congestive Heart Failure (CHF) when using a ...
... full year as a public company, 2010, the biotechnology developer Divine ... and grew Q4 revenue by 88 percent over the previous Q4, ... $5.4 million, up by $1.9 million over the previous year. Fourth-quarter ... quarter of 2009. The maker of topical treatments for ...
Cached Biology Technology:Harvest Technologies Announces Initial Enrollment in Its REVIVE-1 Trial (REtrograde Vascular Infusion of BMAC to ImproVe Heart FailurE) 2Divine Skin Posts Record Sales for 2010: Up 55% Over 2009 2Divine Skin Posts Record Sales for 2010: Up 55% Over 2009 3
(Date:7/22/2014)... 14, 2014, by lightning from a weather system that moved ... fires: Stokes Fire, Gold Hikes Fire, French Creek Fire and ... now one larger fire. The fires are burning in timber ... acres in size. The present fire situation continues to ... firefighter safety is the priority on the Carlton Complex fires. ...
(Date:7/22/2014)... for Health Policy and Economics have linked tighter ... rates for schizophrenic individuals. , The study comes ... health actually save money, when other costs are ... an extra approval step before tests or treatments ... called prior authorization is intended to encourage ...
(Date:7/22/2014)... research team from the National Institute of Standards ... has demonstrated a dramatically improved technique for analyzing ... vibration "signatures." The new NIST technique is an ... spectroscopy, but one that delivers signals that are ... scattering, and 100 times stronger than obtained from ...
Breaking Biology News(10 mins):Are state Medicaid policies sentencing people with mental illnesses to prison? 2Enhanced NIST instrument enables high-speed chemical imaging of tissues 2Enhanced NIST instrument enables high-speed chemical imaging of tissues 3
... (RFRH) systems with mulches were first researched in the ... water availability and to increase crop production. In RFRH ... bare or mulched furrows serve as planting zones. The ... in many parts of the world as a means ...
... of 34 institutions in 15 countries contributing to the measurements ... network, InGOS. , The network focuses on providing accurate information ... for a more vigorous climate action. In order to ... of greenhouse gas emissions is essential and not only ...
... article in the New England Journal of Medicine ... B was able to convert severe hemophilia to moderate or ... Methods Editor for Human Gene Therapy and ... represents an important milestone and "demonstrates unequivocally that gene therapy ...
Cached Biology News:Improved rainwater harvesting system promising 2DTU is participating in a European network on measurement of greenhouse gases 2Commentary and podcast on landmark gene therapy clinical trial for hemophilia B 2